CRISPR and Gene Editing in Cancer Therapy

CRISPR and gene editing technologies have revolutionized the field of cancer therapy by providing the ability to precisely alter the genetic makeup of cancer cells. CRISPR, a tool that enables targeted gene editing, allows researchers to deactivate cancer-causing genes or correct genetic mutations that contribute to tumor growth. This technology holds the potential to not only treat cancer by directly targeting tumor cells but also to enhance the immune system’s ability to recognize and destroy cancer cells. Additionally, CRISPR could be used to modify immune cells, such as T cells, to improve their efficacy in fighting cancer. While still in the early stages, CRISPR-based therapies have shown promise in preclinical studies and clinical trials, offering new hope for more effective and personalized cancer treatments.